Study Identifies EXO1 as Potential Therapeutic Target in Ewing Sarcoma
Researchers have identified that Ewing sarcoma cells are markedly dependent on the enzyme exonuclease 1 (EXO1) for survival and tumor growth. EXO1 facilitates a DNA repair process called mitotic DNA synthesis (MiDAS), which counteracts replication stress caused by the EWSR1::FLI1 fusion oncoprotein that drives the cancer. The findings suggest that targeting EXO1 or related DNA damage response factors could represent a new therapeutic strategy for this aggressive malignancy.
Ewing sarcoma (EwS) is an aggressive cancer primarily driven by EWSR1::ETS gene fusions, most commonly EWSR1::FLI1, which are known to cause replication stress and genome instability. Prior attempts to directly or indirectly target these fusion oncoproteins have produced limited clinical benefit, motivating the search for alternative vulnerabilities. In this study, researchers identified a strong dependency of EwS cells on exonuclease 1 (EXO1), a DNA repair enzyme. They demonstrated that loss of EXO1 impairs mitotic DNA synthesis (MiDAS), a specialized repair mechanism that resolves under-replicated DNA during cell division, leading to increased genome instability and cell death specifically in EwS cells. These results position EXO1 as a novel and potentially selective therapeutic target. More broadly, the work supports a strategy of targeting DNA damage response factors that normally compensate for the replication stress induced by fusion oncoproteins in EwS and potentially other fusion-driven cancers.
What's missing
The study is a preprint posted to bioRxiv and has not yet undergone formal peer review, so findings should be interpreted with caution. Key open questions include whether EXO1 inhibition shows selectivity for EwS cells over normal cells (therapeutic window), whether resistance mechanisms emerge, and whether these findings translate to patient-derived samples beyond what was tested. No EXO1-specific clinical inhibitors currently exist, leaving the translational path undefined.
What different sources said
- bioRxivCenter
EXO1 Facilitates MiDAS and Prevents Genome Instability and Cell Death in Ewing Sarcoma
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.